Our data show that bFGF promotes VEGF-C expression and increases lymphangiogenesis by downregulating miR-381 through the PDGFR and Akt signaling pathways, rendering bFGF as a novel target for chondrosarcoma lymphangiogenesis. This evidence concerns the gene AKT1 and chondrosarcoma.